Apollon Formularies PLC: Apollon Formularies plc Announces CEO Review of 2021

LONDON, UK / ACCESSWIRE / January 25, 2022 / Apollon Formularies plc (AQSE:APOL)("Apollon" or the "Company"), a UK based international pharmaceutical company specializing in medical cannabis and trading

Related Keywords

United States ,University Of The West Indies ,Saint Andrew ,Jamaica ,United Kingdom ,Texas ,Houston ,University Of Texas ,London ,City Of ,Negril ,Westmoreland ,America ,Jamaican ,American ,Stephend Barnhill ,Herb Fritsche ,Anthony Hall ,Archibald Mcdonald ,Al Dawes ,Marjorie Vassell ,Megan Ray ,Stephen Barnhill Jr ,Tim Blythe ,Stene Jacobs ,Jodi Anne Mckenley King ,Dingle Spence ,Cannabis License Authority ,Faculty Of Medical Sciences ,National Cancer Institute ,Jazz Pharmaceuticals ,Ministry Of Health ,Md Anderson Cancer Center ,Institute Is Dr ,Apollon International Cancer ,Gw Pharmaceuticals ,Expert Panel ,Chronic Pain Institute ,Apollon Formularies Jamaica Ltd ,Mcdonald ,Public Service ,International Cancer ,Bloomberg ,London Stock Exchange ,Wellness Ethics Panel ,Apollon Formularies Inc ,Apollon Formularies ,Drug Administration ,Head Of Corporate Development ,Professor Of Laboratory Medicine ,Peterhouse Capital Limited Corporate Adviser ,University Dean ,Our Research ,Chief Executive Officer ,Fellow Shareholders ,Big Pharma ,Medical Cannabis With ,Arena Pharmaceuticalspublished ,Global Opportunity Analysis ,Industry Forecast ,Pre Clinical Cancer Testing ,Apollon Cancer Formulations ,Chief Science Officer ,Clinical Chemist ,Laboratory Medicine ,Clinical Chemistry Section ,Cancer Center ,Tumor Marker Practice Guidelines ,American Society ,Clinical Oncology ,Laboratory Practice Guidelines Committee ,National Academy ,Clinical Biochemistry ,Editorial Board ,Chronic Pain ,Medical Director ,Radiation Therapy ,Palliative Care ,Honorable Archibald Mcdonald ,Professor Emeritus ,Former University Dean ,Medical Sciences ,Pro Vice Chancellor ,West Indies ,Professor Mcdonald ,Current Chairman ,Wellness Ethics ,License Authority ,Stephen Barnhill ,Chief Operating ,North America ,Apollon Formularies Jamaica ,Corporate Development ,Rod Mcillree ,Capital Limited ,Corporate Adviser ,London Stock ,Napollon ,Formularies ,Nnounces ,Review ,021 ,